News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Hannah Kenny, MD

Articles by Hannah Kenny, MD

Neoadjuvant Cemiplimab in BCC of the Head and Neck | Image Credit: © Galina - stock.adobe.com

Dr Kenny on Phase 2 Data With Neoadjuvant Cemiplimab in BCC of the Head and Neck

ByHannah Kenny, MD,Joseph M. Curry, MD

July 16th 2026

Hannah Kenny, MD, and Joseph M. Curry, MD, discuss findings from a phase 2 study of cemiplimab in locally advanced BCC of the head and neck.

Latest Updated Articles

Trending on OncLive

Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer

CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma

Copper-Induced Cell Death Activates Immune System, May Help Overcome Immunotherapy Resistance

Dr Fecci on Immunotherapy Research Innovations in Glioblastoma